Seres Therapeutics (MCRB) Tops Q3 EPS by 94c
Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.94. Revenue for the quarter came in at $350 thousand.
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.
Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.94. Revenue for the quarter came in at $350 thousand.
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.